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AbstrAct
Objectives To investigate whether overstatements in 
abstract conclusions influence primary care physicians’ 
evaluations when they read reports of randomised 
controlled trials (RCTs)
Design RCT setting: This study was a parallel-group 
randomised controlled survey, conducted online while 
masking the study hypothesis.
Participants Volunteers were recruited from members of 
the Japan Primary Care Association in January 2017. We 
sent email invitations to 7040 primary care physicians. 
Among the 787 individuals who accessed the website, 622 
were eligible and automatically randomised into ‘without 
overstatement’ (n=307) and ‘with overstatement’ (n=315) 
groups.
Interventions We selected five abstracts from published 
RCTs with at least one non-significant primary outcome 
and overstatement in the abstract conclusion. To 
construct a version without overstatement, we rewrote 
the conclusion sections. The methods and results sections 
were standardised to provide the necessary information of 
primary outcome information when it was missing in the 
original abstract. Participants were randomly assigned to 
read an abstract either with or without overstatements and 
asked to evaluate the benefit of the intervention.
Outcome measures The primary outcome was the 
participants’ evaluation of the benefit of the intervention 
discussed in the abstract, on a scale from 0 to 10. A 
secondary outcome was the validity of the conclusion.
results There was no significant difference between the 
groups with respect to their evaluation of the benefit of the 
intervention (mean difference: 0.07, 95% CI −0.28 to 0.42, 
p=0.69). Participants in the ‘without’ group considered 
the study conclusion to be more valid than those in the 
‘with’ group (mean difference: 0.97, 95% CI 0.59 to 1.36, 
P<0.001).
conclusion The overstatements in abstract conclusions 
did not significantly influence the primary care physicians’ 
evaluations of the intervention effect when necessary 
information about the primary outcomes was distinctly 
reported.
trial registration number UMIN000025317; Pre-results.
IntrODuctIOn
Abstracts of reports of randomised controlled 
trials (RCTs) provide concise, educational 
and readily accessible information. They are 
particularly useful for primary care physi-
cians because they deal with a wide range of 
patients and problems and need quick access 
to information regarding their practices. 
Sometimes abstracts are the only source of 
evidence they use.1 
Abstract conclusions are the most crucial 
part of the whole abstract as they summarise 
the main results and provide interpretations.2 
A previous survey showed that primary care 
physicians paid the most attention to the 
conclusion.3 The conclusion also guides 
primary physicians who are not confident 
in their skills in evidence-based medicine 
(EBM)3 4 to interpret the results. Thus, a 
strong conclusion may alter the readers’ 
interpretation of the whole study.
Unfortunately, the conclusion is the most 
frequently distorted section in abstracts.5 Exag-
gerating the results of the trial, such as using 
spin5 or overstatement,6 is not uncommon. 
Examples of spin include omitting non-sig-
nificant results of primary outcomes and 
focusing on significant secondary outcome 
or subgroup analysis.5 Previous studies also 
found that 58% of RCTs with non-signifi-
cant results,5 and 70% of non-randomised 
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Research
strengths and limitations of this study
 ► This is the first and only randomised controlled trial 
study that estimates the influence of overstatement 
in abstract conclusions.
 ► We evaluated the influence of overstatement among 
primary care physicians who were one of the major 
users of evidence.
 ► Although the number of participants was above our 
targeted sample size, a relatively low response rate 
limits the generalisability of our findings.
 ► As we focused on the influence of overstatement in 
abstract conclusions when necessary information 
about primary outcomes was reported in the 
methods and results sections, the effect of various 
other forms of inadequate reporting in abstracts 
should be further evaluated.
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studies7 had spin. Subsequent studies reported that spin, 
misleading information or overstatements were common 
in various subspecialties, such as rheumatology,8 psychi-
atry,9 wound care,10 surgery11 12 and oncology.13–15
This suggests that, as far as abstract conclusions 
are concerned, the quality of reporting is still poor 
despite the consolidated standards of reporting trials 
(CONSORT) guideline for abstracts.2
However, there has been limited evidence about the 
influence of such abstracts on the readers’ interpreta-
tions in the real world. Only one RCT16 investigated 
the extent of the impact of inappropriate reporting on 
readers’ interpretations of the results. Boutron et al16 
randomised clinical researchers into two groups, and 
asked them to read an abstract with or without ‘spin’, 
which was defined by the authors as ‘reporting the bene-
ficial effect of the intervention as greater than shown by 
the results’, to estimate how readers were influenced 
when they assessed the effectiveness of the interven-
tion. The result showed that the participants who read 
abstract with spin were more likely to think that the 
intervention was beneficial for the patients than those 
who read the abstracts without spin.
Although their trial demonstrated that spin in the 
abstract had a small impact (effect size=0.24), it left several 
questions unanswered. First, the level of influence of spin 
in the abstract conclusion on the participants’ interpre-
tation remained unclear because the investigators added 
changes to all sections of the abstracts. In their study, 
they either erased or added all the results of secondary 
outcomes while changing the wording. In other words, 
they investigated the general influence of spin in an 
abstract by comparing it with its ‘paragon’ counterpart. 
Moreover, the target population was clinical researchers 
with publishing experience. Therefore, the influence of 
spin in the abstract conclusion on other types of evidence 
users remains unknown.
This study aims to determine the influence of the over-
statements in abstract conclusions on general clinical 
practice by focusing on the primary care physicians who 
read reports of RCTs.
MethODs
setting and design
This online study was a double-blind RCT conducted 
from January to February in 2017. The participants were 
masked to the study hypothesis, and the investigators 
(except RS who constructed the random sequence) were 
masked from the allocation. We recruited volunteers 
from members of the Japan Primary Care Association 
(JPCA) by sending email invitations. The intervention 
was conducted on a website specifically designed for this 
study. Participants were randomised into two groups and 
asked to read and evaluate 1 of the 10 abstracts (five pairs 
of two corresponding abstracts: one with and another 
without overstatement) of an RCT report. The trial was 
prospectively registered with the University Hospital 
Medical Information Network—Clinical Trial Registry 
(UMIN000025317) and now it is at "sutdy completed" 
stage. We had submitted the protocol including a statis-
tical analysis plan to the JPCA before commencement but 
did not publish it to avoid the risk of participants reading 
it.
Participants and recruiting
The target population was recruited from the members 
of the JPCA. The JPCA was established in 2010 to the 
promote primary care specialty in Japan.17 It is the largest 
organisation for primary care physicians in the country, 
and has been promoting evidence-based practice among 
its members. Currently, over 10 000 doctors working in 
various types of medical institutions18 belong to the JPCA, 
and 5836 out of a total of 10 851 members are certified as 
specialists in primary care.
We sent email invitations to JPCA members who had 
more than 2 years of clinical experience with registered 
email addresses. (The details of the recruiting process will 
be reported in a separate paper.) We excluded clinicians 
with less than 2 years’ experience because our target popu-
lation was primary care physicians, and doctors usually 
choose their specialty after 2 years of clinical training in 
Japan. Interested individuals could access the DOCTOR 
study website via the link in the email. We added a code at 
the end of the link to ensure that participants accessed the 
website via the given link. As an incentive, an Amazon gift 
card worth 3000 yen (US$26.6) was given to 20 drawing 
winners.
The inclusion criteria for participants were as follows: 
JPCA member, medical doctor currently in clinical prac-
tice, more than 2 years of clinical practice experience and 
access to up-to-date clinical research knowledge. We asked 
how respondents learnt about the recent clinical trials, 
and individuals who did not respond with any informa-
tion source were excluded. Screening questions were on 
the leading page on the website. We excluded those who 
work at research laboratories or educational institutions.
randomisation and allocation concealment
When participants moved to the assessment page, they 
were randomly assigned an abstract either with or without 
overstatements with a 1:1 ratio. The block randomisation 
(10 for each block) was automatically performed using a 
computer-generated random sequence (created by RS). 
The allocation concealment was maintained through the 
automatic random allocation process.
blinding
In the email invitations, participants were notified that this 
study aimed to investigate the impression of the abstracts 
and that they would be asked to score one randomly selected 
abstract numerically. (The English version of the invitation 
is included in the online supplementary appendix 1). Thus, 
they were masked to the study hypothesis. The researchers 
(KS, TA, YT and AS), excluding the website manager (RS), 
were blinded until the blind interpretations of the results 
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box An example of the abstracts (italics where extra text 
added, bold where changed in the ‘without overstatement’ 
group)
title
Intervention A for menopausal symptoms: a randomised controlled trial
Objective
This study aims to determine the efficacy of intervention A for 
alleviating vasomotor and other menopausal symptoms.
Methods
Late perimenopausal and postmenopausal sedentary women with 
frequent vasomotor symptoms (VMS) such as hot flush, sweating 
and poor circulation participated in a randomised controlled trial 
conducted in three sites: 106 women randomised to exercise and 142 
women randomised to usual activity. VMS frequency and bother were 
recorded on daily diaries at baseline and on weeks 6 and 12. Intent-
to-treat analyses compared between-group differences in changes 
in VMS frequency and bother, sleep symptoms (Insomnia Severity 
Index and Pittsburgh Sleep Quality Index), and mood (Patient Health 
Questionnaire-8 and Generalised Anxiety Disorder-7 Questionnaire). 
Primary outcomes were VMS frequency and bother mean frequency or 
bother of VMS at 6 and 12 weeks.
results
At the end of week 12, changes in VMS frequency in intervention A 
group (mean change −2.4 VMS/d, 95% CI −3.0 to −1.7) and VMS 
bother (mean change on a four-point scale −0.5, 95% CI −0.6 to 
−0.4) were not significantly different from those in control B group 
(−2.6 VMS/d, 95% CI −3.2 to −2.0, P=0.43, −0.5 points, 95% CI −0.6 
to −0.4, P=0.75). The exercise group reported greater improvement 
in insomnia symptoms (P=0.03), subjective sleep quality (P=0.01) 
and depressive symptoms (P=0.04), but differences were small and 
not statistically significant when p values were adjusted for multiple 
comparisons. Results were similar when considering treatment-
adherent women only.
conclusions
these findings provide strong evidence that 12 weeks of 
intervention A do not alleviate VMs but may result in small 
improvements in sleep quality, insomnia and depression in 
midlife sedentary women.
Control B is the standard treatment for menopausal symptoms.
‘Without’ overstatement version conclusions
Intervention A was not more effective than control B in terms of 
frequent VMS such as hot flush, sweating in postmenopausal women.
Control B is the standard treatment for menopausal symptoms.
were completed and signed off.19 RS did not join the result 
analysis.
selecting abstracts with overstatements
We selected five abstracts20–24 (the text of the five abstracts 
is included in the online supplementary appendix 2) from 
the pre-existing database of published reports in psychiatry 
RCTs dated between 2011 and 2014, which was collected 
from our previous study.6 25 To avoid any bias arising from 
the participants’ subspecialty expertise (such as internal 
medicine or surgery), we chose reports from psychiatry.
The abstracts were selected based on the following 
criteria: (1) superiority RCT with two arms, (2) claiming 
effectiveness of an intervention in the abstract conclu-
sion despite some or all primary outcomes not being 
significant, (3) targeting a common mental illness 
primary care physicians are likely to encounter in clin-
ical settings and (4) having a journal impact equal to or 
higher than two.
An overstatement was defined as ‘inconsistency between 
the results of primary outcomes in full-text and those 
deduced from the abstract conclusion’.6 While spin is any 
technique embellishing the results across whole reports, 
an overstatement specifically refers to exaggerations in 
the abstract conclusion.
In the five sample abstracts selected, two only mentioned 
the superiority of the intervention to the control in the 
conclusions. In fact, one had non-significant results and 
the other had mixed results (significant and non-signif-
icant) in their primary outcomes. The remaining three 
had conclusions that emphasised the partial superiority 
of the intervention with respect to the control. They 
stated that the treatment was partially effective even 
though all the primary outcomes were non-significant. 
Together, they include different levels of overstatement 
from completely misleading to less informative (not 
mentioning non-significant primary outcome) conclu-
sions. They were checked independently by two or more 
investigators (KS, AS and RS)
constructing abstracts with and without overstatements
We constructed abstracts in line with the following 
prespecified guidelines. First, we rewrote the conclu-
sion to make a conclusion without overstatement 
following these rules. (1) When all primary outcomes 
were non-significant, we rewrote it the conclusion as 
‘Intervention A was not more effective than control B in 
terms of …’. (2) When one primary outcome (PO1) was 
significant but the other (PO2) was non-significant, we 
rewrote it the conclusion as ‘Intervention A was more 
effective than control B in terms of PO1, but not more 
effective in PO2’ according to the order in the orig-
inal abstract. We also removed the results of secondary 
outcomes and subgroup analysis from the conclusions. 
(See an example in box, and all the abstract conclu-
sions are in table 1.)
Second, we standardised the methods and results 
sections. We explicitly stated the primary outcomes and 
results (for example, OR, risk ratio, CI, P value) from 
the text if they were not stated in the original abstract. 
Therefore, all abstracts had the information necessary 
for participants to understand the results of the primary 
outcomes from the method and results sections. This 
modification was necessary to keep the conclusion consis-
tent with the other sections of the abstract. Without this 
step, the conclusion of an abstract without overstatement 
would be inconsistent with other sections of the same 
abstract because the conclusion of an abstract without 
overstatement would now be reconstructed based on the 
actual primary outcomes that were not mentioned in the 
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Table 1 Five sample abstracts and their two versions of conclusion
Study
year Symptoms or illness Conclusion in the original abstract






These findings provide strong evidence 
that 12 weeks of intervention A do not 
alleviate vasomotor symptoms (VMS) but 
may result in small improvements in sleep 
quality, insomnia and depression in midlife 
sedentary women.
Intervention A was not more effective 
than control B in terms of frequent 









These results support that intervention A, 
with its benign safety profile, can be used 
as first-line treatment of NPSD, unless 
symptoms of irritation and agitation are 
prominent, where control B is more efficient.
Intervention A was not more 
effective than control B in terms of 






Intervention A with escitalopram 
significantly improved some self-reported 
work functioning outcomes, but not 
symptom-based outcomes, compared with 
escitalopram and control B.
Intervention A with escitalopram was 
not more effective than control B with 
escitalopram in terms of depressive 






Intervention A resulted in an earlier treatment 
response compared with control B
Intervention A was not more effective 
than control B in terms of treatment 




Elders with memory 
disorders
Intervention A delivered by non-clinical 
community workers trained and overseen by 
geriatric clinicians led to delays in transition 
from home, reduced unmet needs and 
improved self-reported QOL. 
Intervention A was more effective than 
control B in terms of delay in transition 
from home, but not more effective 
in terms of reducing unmet needs in 
elders with memory disorders.
QOL, quality of life.
original abstract. Additionally, this standardisation made 
it possible to estimate the influence of overstatement in 
the conclusion when the methods and results reported 
essential information.
Third, we changed the names of the intervention and 
control treatments to anonymous ‘intervention A’ and 
‘control B’ to minimise bias. We added a few words for 
explanation when there was a medical term that seemed 
unfamiliar to primary care physicians (eg, VMS): hot flush, 
sweating and poor circulation). Finally, we translated the 
texts into Japanese. Except for the conclusion, abstracts 
‘with’ or ‘without’ overstatement were identical.
We made established two pairs of investigators, and 
each pair did modification and translation of a half of the 
abstracts (‘with’ and ‘without’ overstatement). Then, the 
other pair then checked whether they were following the 
guidelines. Another researcher (SK), who was not involved 
in this study, checked the translation. Any disagreement was 
resolved by discussion among investigators.
Outcomes
Our primary outcome was the numerical evaluation, 
which was scored by participants, of the effectiveness of 
the intervention discussed in the given abstract: ‘How 
beneficial do you think intervention A is for the patients, 
on a scale from 0 to 10, 0 being not at all beneficial and 
10 being conceivably most beneficial?’ We also asked the 
following questions (scored 0 to 10 with 0 being not at all 
and 10 being very likely).
 ► How valid is this conclusion in your opinion on a scale 
from 0 to 10?
 ► How much do you want to read the full text of this 
study on a scale from to 10?
 ► When you answered the above questions, which part of 
the abstract did you refer to the most? (background/
methods/ results/conclusion)
sample size
We referred to the effect size of 0.25 obtained in the 
previous study.16 They estimated the effect of spin by 
comparing the influence of the abstracts ‘with’ and 
‘without’ spin on clinical researchers. Although our target 
population differed from the previous study, considering 
that the effect of 0.2 represented a small effect,26 we 
aimed for a sample size of 253 per group, and 506 in total 
to detect a between group effect size of 0.25 with a power 
of 90% and a two-sided alpha risk at 5%. Given that we 
had prepared five pairs of abstracts with or without over-
statement, we intended to enrol 100 or more participants 
for each pair.
statistical analysis
For the main analysis, we used a linear mixed effects 
model with a fixed factor (for the intervention) and a 
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Figure 1 Flow diagram of participants. JPCA, Japan 
Primary Care Association.
random intercept for the abstract to account for the 
clustering effects of the abstracts (each abstract had two 
versions: with or without overstatements). The model 
accounted for the correlation within abstracts by using 
an unstructured covariance matrix. We excluded the 
following subjects from our analysis before proceeding 
to the study analyses and therefore without knowledge 
of any outcomes: (1) those who were erroneously allo-
cated by the web system although they did not satisfy 
the eligibility criteria and (2) those who were eligible 
and were randomised but did not complete the ques-
tionnaire or spent less than 30 s on the questionnaire. 
TA and KS analysed the data using SPSS statistics 24 
without knowing the allocation. To evaluate the influ-
ence of possible associated factors3 27 on the interpreta-
tion, we conducted the following prespecified subgroup 
analyses using the participants: (1) working clinics, 
(2) getting information only from a pharmacological 
company, (3) with certification of a primary care physi-
cian and (4) having an experience of being the prin-
cipal researcher (this is post hoc).
blinded data interpretation
Blinded interpretation of study results was the approach 
recommended by Järvinen et al19 to reduce interpreta-
tion bias. Following their suggestion, we interpreted the 
results blindly before breaking the randomisation code. 
Thus, we prepared two interpretations of the results 
based on two scenarios: (1) assuming group A was with 
overstatement and group B was without overstatement 
and (2) assuming group A was without overstatement 
and group B was with overstatement. After agreeing that 
there would be no further change, we broke the rando-
misation code and chose the correct interpretations.
ethical considerations
This study was conducted in accordance with the Decla-
ration of Helsinki. We obtained an online consent for 
participation from each participant. 
results
We sent email invitations to 7040 JPCA members 
(figure 1). After sending one reminder, we reached the 
targeted sample size of 510. Among the 787 individuals 
who accessed the website, 622 were eligible and randomly 
assigned to without overstatement (n=307) and with 
overstatement (n=315) groups. A total of 281 doctors 
in the ‘without’ group and 286 in the ‘with’ group were 
included for the analysis. The number of participants 
allocated to each pair ‘with’ or ‘without’ overstatement 
was as follows: abstract pattern 1 (n=116), 2 (n=109), 
3 (n=115), 4 (n=113) and 5 (n=114). Online supple-
mentary appendix 3 provides further breakdown per 
abstract.
Fifty-five individuals were excluded because they either 
spent less than 30 s on the webpage (n=14) or did not 
complete the survey (n=41). Most participants read and 
rated the abstract within 4 min (medium time: 162 s, IQR: 
114–236 s).
Table 2 shows the participant characteristics; 76.5% 
were certified as primary care physicians. We classified 
their subspecialties according to their certifications. The 
most common background was internal medicine. More 
than 60% of the participants had attended a course on 
EBM. About 40% of the physicians said the first section 
they read was the conclusion; only 11% of them read the 
results section first. There was no substantial difference 
between the two groups.
Primary outcomes
There was no statistically significant difference 
between the groups with regard to the interpretation 
of the benefits of the intervention discussed in the 
given abstracts (mean difference: 0.07, 95% CI −0.28 
to 0.42, P=0.69, effect size calculated by Cohen's d: 
0.031) (table 3).
secondary outcomes and subgroup analyses
However, there was a significant difference between 
the groups in their perception of the validity of the 
conclusion (mean difference: 0.97, 95% CI 0.59 to 1.36, 
P<0.001) (figure 2). Those in the without overstate-
ment group considered the abstract to be more valid 
than those in the with overstatement group (effect 
size calculated by Cohen’s d was 0.41). No signifi-
cant difference was found when asked if they wanted 
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Table 2 Characteristics of participants
Characteristics of doctors Without OS , n=281 (%) With OS, n=286 (%) Total, n=567(%)
Male 241 (85.8) 243 (85.0) 484 (85.4)







  Hospitals (public and private) 131 (46.6) 165 (57.7) 296 (52.2)
  Clinics 97 (34.5) 80 (28.0) 177 (31.2)
  University hospitals 46 (16.4) 40 (14.0) 86 (15.2)
  Nursing homes 2 (0.7) 0 (0) 2 (0.4)
  Others 5 (1.8) 1 (0.3) 6 (1.1)
Certification/degree*
  Primary care physician 216 (76.9) 218 (76.2) 434 (76.5)
  PhD 88 (31.3) 93 (32.5) 181 (31.9)
  Other certification 167 (59.4) 180 (62.9) 347 (61.2)
Clinical background*
  Internal medicine 123 (43.8) 135 (47.2) 258 (45.5)
  Surgery 26 (9.3) 26 (9.1) 52 (9.2)
  Emergency medicine 15 (5.3) 14 (4.9) 29 (5.1)
  Paediatrics 6 (2.1) 5 (1.7) 11 (1.9)
  Others 21 (7.5) 22 (7.7) 43 (7.6)
Source of information*
  Brochures/lectures sponsored by pharmaceutical 
companies 153 (54.4) 165 (57.7) 318 (56.1)
  Journal club 81 (28.8) 83 (29.0) 164 (28.9)
  Searching evidence/medical journals 187 (66.5) 193 (67.5) 380 (67.0)
  Secondary information 191 (68.0) 199 (69.6) 390 (68.8)
  Others 21 (7.5) 9 (3.1) 30 (5.3)
Ever attended an EBM workshop 181 (64.4) 186 (65.0) 367 (64.7)
Experience of PI 94 (33.5) 106 (37.1) 200 (35.3)
The first section to read when studying abstracts
  Background 108 (38.4) 105 (36.7) 213 (37.6)
  Methods 24 (8.5) 25 (8.7) 49 (8.6)
  Results 35 (12.5) 30 (10.5) 65 (11.5)
  Conclusion 114 (40.6) 126 (44.1) 240 (42.3)
The number of abstract read in the last month
  0 22 (7.8) 26 (9.1) 48 (8.5)
  1 23 (8.2) 31 (10.8) 54 (9.5)
  2–4 107 (38.1) 117 (40.9) 224 (39.5)
  Five or more 129 (45.9) 112 (39.2) 241 (42.5)
Clinical background data were available with participants who have subspecialty certifications.
*Multiple answers allowed.
EBM, evidence-based medicine; OS, overstatement; PI, principle investigator.
to read the full text. In both groups, the majority of 
the doctors referred to the results section to make an 
assessment.
We conducted subgroup analyses, but no significant 
differences were found with regard to the interpre-
tation of the benefits of the intervention based on 
the workplace (clinic, n=177, mean difference: 0.04, 
95% CI −0.67 to 0.74, P=0.91), general source of infor-
mation (only pharmacological company, n=43, mean 
difference: 0.06, 95% CI −1.36 to 1.48, P=0.93), being 
a certified primary care physician (n=434, mean differ-
ence: −0.01, 95% CI −0.41 to 0.39, P=0.96) or having 
 7Shinohara K, et al. BMJ Open 2017;7:e018355. doi:10.1136/bmjopen-2017-018355
Open Access
Table 3 Impression of the abstract








Effect size (Cohen’s d)
n=567 (95% CI)
How beneficial do you think intervention A is for 
the patients? 4.18 (2.29) 4.10 (2.17) 0.07 (−0.28 to 0.42) 0.031 (−0.13 to 0.20)
How valid is this conclusion in your opinion? 4.84 (2.40) 3.88 (2.36) 0.97*** (0.59 to 1.36) 0.41 (0.24 to 0.57)
How much do you want to read the full text of 
this study? 3.52 (2.55) 3.41 (2.62) 0.10 (−0.32 to 0.53) 0.039 (−0.13 to 0.20)
When you answered the above questions, which 
part of the abstract did you refer to the most?
Background 2 (0.7) 5 (1.7)
Methods 58 (20.6) 59 (20.6)
Results 181 (64.4) 174 (60.8)
Conclusion 40 (14.2) 48 (16.8)
***P<0.001.
Figure 2 Evaluation of the beneficial effect and validity 
of the intervention discussed in the abstract. The answers 
to q1 “How beneficial do you think the intervention A is to 
patients?”, and q2 “How valid is this conclusion in your 
opinion?” given in a scale of 0 (not at all) to 10 (very likely). 
Boxes showed the median score (horizontal rule) with 25th 
and 75th percentile.
no experience as a principal researcher (n=367, mean 
difference: −0.10, 95% CI −0.53 to 0.34, P=0.66).
DIscussIOn
We showed that primary care physicians were not influ-
enced by overstatement in the conclusion section if the 
abstract contained necessary information on the primary 
outcomes. The 95% CI of the estimated effect (effect size 
by Cohen's d: 0.031, 95% CI −0.13 to 0.20) rules out the 
existence of even a small effect. In the baseline question-
naire, 42% of participants answered that they read the 
conclusion section first when reading abstracts. However, 
more than 60% of them referred to the results section for 
their interpretation of the given abstract. They tended to 
judge the overstated conclusion as less valid than those 
without overstatement. These results suggested that 
primary care physicians who belonged to the JPCA with 
up-to-date knowledge of clinical trials were not misled 
by overstatements in abstract conclusions if the method 
and results section reported sufficient information. Our 
subgroup analysis showed that factors such as the work-
place, types of information resources or experience of 
being a principal investigator would make little differ-
ence. These results suggest that the participants had good 
critical appraisal skills of research reports, which helped 
them to recognise the inconsistency between the result 
and the conclusion.
Our results differed in some respects from the 
previous study. Boutron and colleagues’ study16 showed 
that the interpretation of abstracts was affected by spin. 
The ‘abstracts with spin’ group considered the interven-
tion more beneficial than the without spin group, and 
the ‘with spin’ group was more interested in reading the 
full text. This was contrary to our main findings. On the 
other hand, the abstracts with spin group interpreted 
the abstract as less methodologically rigorous than the 
without spin group. This was consistent with our results.
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However, we must consider some differences in 
design between Bourton et al’s study and this study. 
First, the level of spin was much higher in their study 
than in this study. Boutron et al aimed to investigate 
the impact of spin in the abstract generally, so they 
removed all spin from the abstract and compared this 
‘perfect’ abstract with the original one. On the other 
hand, in our study, the difference between ‘with’ and 
‘without’ groups was limited in the conclusion section 
because our aim was to estimate the influence of over-
statement in the conclusion section. Thus, we added the 
information on the primary outcomes in the methods 
and results sections of both groups. Second, the base-
line characteristics of the participants differed. While 
all the participants in the study of Boutron et al were 
experienced clinical researchers, we chose primary care 
physicians as our target. Although the participants in 
this study had little experience in clinical research, they 
were regular users of medical literature (90% of partic-
ipants had read more than one abstract in the previous 
month). Most participants were eager to learn EBM and 
had some knowledge of critical appraisal. In addition, 
60% referred to the results section when making clin-
ical interpretation. Therefore, their study and ours are 
more complementary than contradictory.
limitations and strengths
Our strength is that this is the first and only RCT study 
that estimates the influence of overstatement in abstract 
conclusions. Authors of scientific articles like to use prom-
ising, positive words28 29; nonetheless, we demonstrated 
that overstated conclusions did not affect the readers’ 
interpretations of the results if sufficient information was 
provided in other sections. Second, we evaluated the influ-
ence of overstatement in primary care physicians, who are 
among the major users of evidence. They encounter clin-
ical queries in daily clinical practice and use evidence to 
make the best decisions for their patients. Therefore, it is 
important to clarify whether primary care physicians are 
susceptible to overstatement in abstract conclusions. The 
results showed that primary care physicians with up-to-
date knowledge of trial/research information were not 
misled by an overstated conclusion.
There are some limitations. While the number of 
participants was above our targeted sample size, it may 
not have completely represented the JPCA members. 
The relatively low response rate of 11.1% (787/7040) 
limits the generalisability of our findings. Two things 
should be noted. First, we chose the JPCA as our 
recruiting pool because that the members were consid-
ered representative of active users of scientific evidence 
in their primary care practice. The JPCA is the only 
organisation that certifies clinicians as primary care 
physicians, and they regularly conduct workshop on 
EBM. However, those who responded to our invitation 
were potentially avid readers of scientific reports, which 
is the reason they volunteered for this assessment, and, 
therefore, they may have better critical appraisal skills 
for abstracts than other JPCA members. Actually, most 
of participants answered that they read abstracts regu-
larly. This suggests that they were not representative of 
all primary care physicians in Japan. Furthermore, the 
effect of overstatements in the abstracts that did not 
report the necessary information of primary outcomes 
or other various forms of inadequate reporting was not 
measured. In our study, we added essential information 
on primary outcomes in the methods and results sections 
as recommended by a CONSORT statement.2 More 
than 60% of the participants stated that they mainly 
refer to the results to evaluate the abstract. In contrast, 
only around 15% based their assessment on the conclu-
sion. This means that adequate reporting of the results 
is necessary for interpretation of the abstract. Finally, 
we should not overgeneralise the association between 
the type or level of overstatement and its impact on 
interpretation. We chose five abstracts at different levels 
of overstatement as a sample, but the selection did not 
cover all levels of spin or all types of spin. Neither did 
we have sufficient sample size to explore such relation-
ships. The influence of biased reporting on clinical 
decisions should be further researched.
In conclusion, our findings suggested that sensible and 
well-read clinicians are capable of discerning the incon-
sistency between results and conclusion and of making 
a sound judgement on the validity of misleading conclu-
sions when primary outcomes are appropriately reported 
in the methods and results sections. However, this does 
not mean that overstatements can be overlooked. The 
conclusion sections of abstracts should be written solely 
based on the primary outcome results. The impact of 
inappropriate writing style in clinical settings should be 
further researched.
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